Clinical Trials Logo
  1. Home
  2. Pain, Post-operative
  3. NCT02675907

Evaluation of N1539 Following Bunionectomy Surgery

Pain, Post-operative Clinical Trial

Official title:
A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Evaluation of the Efficacy and Safety of N1539 Following Bunionectomy

Clinical Trial Summary

The primary objective of this study is to evaluate the analgesic efficacy of N1539 in subjects with acute moderate to severe pain following unilateral bunionectomy.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT02675907
Study type Interventional
Source Recro Pharma, Inc.
Contact
Status Completed
Phase Phase 3
Start date January 2016
Completion date July 2016
View Details
See also
  Status Clinical Trial Phase
Completed NCT02284243 - Placebo-Controlled Evaluation of Intranasal Dexmedetomidine for Postoperative Analgesia Following Bunionectomy Surgery Phase 2
Completed NCT02720692 - Evaluation of N1539 Following Major Surgery Phase 3
Completed NCT03456141 - Multimodal Analgesic Protocol to Moderate Acute Pain
Terminated NCT02169336 - Placebo-Controlled Evaluation of Intranasal Dexmedetomidine for Postoperative Analgesia Following Bunionectomy Phase 2
Not yet recruiting NCT05950152 - Efficacy, Safety and Tolerability Study of Meloxicam Injection in Subjects After Abdominal Surgery Phase 2
Completed NCT02678286 - Evaluation of N1539 Following Abdominoplasty Surgery Phase 3
Unknown status NCT01041313 - Memantine for Post-Operative Pain Control Phase 4
Completed NCT02540265 - Placebo-Controlled Evaluation of N1539 Following Bunionectomy Surgery Phase 2
Completed NCT03154658 - Serratus Anterior Plane Block in Patients Undergoing Mastectomy Phase 4